We are live on ! Find out more
LAB icon

Standard BioTools
LAB

109 hedge funds and large institutions have $252M invested in Standard BioTools in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more call options, than puts

Call options by funds: $12.8M | Put options by funds: $7.69M

14% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 22

2% more funds holding

Funds holding: 107 → 109 (+2)

3% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 35

66% less capital invested

Capital invested by funds: $750M → $252M (-$498M)

Holders
109
Holders Change
+2
Holders Change %
+1.87%
% of All Funds
3.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
36
Reduced
35
Closed
22
Calls
$12.8M
Puts
$7.69M
Net Calls
+$5.15M
Net Calls Change
+$4.4M

Top Buyers

1
SCM
Scopia Capital Management
New York
+$20.6M
2
Capital World Investors
Capital World Investors
California
+$12.6M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$9.97M
4
Citadel Advisors
Citadel Advisors
Florida
+$8.87M
5
Goldman Sachs
Goldman Sachs
New York
+$7.33M

Top Sellers

1
Jennison Associates
Jennison Associates
New York
-$27.6M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$16.7M
3
JP Morgan Chase
JP Morgan Chase
New York
-$14.8M
4
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM)
Texas
-$12.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$12.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$2.53M -$12.3M -780,800 -71%
SAM
27
Senzar Asset Management
New York
$2.52M +$4.89M +310,587 New
Invesco
28
Invesco
Georgia
$2.29M -$5.15M -327,442 -54%
FC
29
FIC Capital
New York
$1.53M – – –
Geode Capital Management
30
Geode Capital Management
Massachusetts
$1.51M +$139K +8,809 +5%
Norges Bank
31
Norges Bank
Norway
$1.33M – – –
Renaissance Technologies
32
Renaissance Technologies
New York
$1.31M +$2.54M +161,512 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.28M -$65.9K -4,189 -3%
TCIM
34
TIAA CREF Investment Management
New York
$897K -$114K -7,274 -6%
BIM
35
BlackRock Investment Management
Delaware
$818K -$32.8K -2,081 -2%
ARTA
36
A.R.T. Advisors
New York
$739K +$1.14M +72,539 +389%
Charles Schwab
37
Charles Schwab
California
$692K -$19.1K -1,215 -1%
Ohio Public Employees Retirement System (OPERS)
38
Ohio Public Employees Retirement System (OPERS)
Ohio
$665K – – –
Principal Financial Group
39
Principal Financial Group
Iowa
$642K +$7.87K +500 +0.6%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$541K -$36.2K -2,300 -3%
TI
41
Trexquant Investment
Connecticut
$522K +$1.01M +64,485 New
CS
42
Credit Suisse
Switzerland
$507K -$114K -7,219 -10%
PAM
43
Paradigm Asset Management
New York
$489K -$61.4K -3,900 -6%
Bank of America
44
Bank of America
North Carolina
$479K +$844K +53,652 +977%
BIM
45
Bogle Investment Management
Massachusetts
$462K +$897K +57,000 New
CS
46
Candriam SCA
Luxembourg
$462K +$897K +57,000 New
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$425K -$3.15K -200 -0.4%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$396K +$392K +24,880 +104%
TA
49
Teachers Advisors
New York
$383K +$1.92K +122 +0.3%
RJA
50
Raymond James & Associates
Florida
$362K -$196K -12,451 -22%
1
2
3 4 5

LAB Hedge Fund Activity: Q3 2015 in Review

109 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2015, worth a combined $252M — down 66% from $750M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new LAB positions and 22 closed out — a net gain of 3 holders — while 36 added to existing stakes and 35 trimmed.

The largest buyer was Scopia Capital Management, opening a new position worth an estimated $20.6M. The largest seller was Jennison Associates, cutting an estimated $27.6M.

  • 109 institutional investors held Standard BioTools (LAB) as of Q3 2015, up from 107 in Q2 2015.
  • Funds reported $252M of Standard BioTools stock for Q3 2015, down 66% quarter-over-quarter.
  • 25 funds opened new Standard BioTools positions in Q3 2015 and 22 closed out, a net change of +3 holders.
  • The largest Standard BioTools buyer in Q3 2015 was Scopia Capital Management, an estimated $20.6M added.
  • The largest Standard BioTools seller in Q3 2015 was Jennison Associates, an estimated $27.6M sold.

Based on aggregated 13F filings for Q3 2015.